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Background: New neurons are continuously being generated in the adult hippocampus, a phenomenon that is
regulated by external stimuli, such as learning, memory, exercise, environment or stress. However, the molecular
mechanisms underlying neuron production and how they are integrated into existing circuits under such
physiological conditions remain unclear. Indeed, the intracellular modulators that transduce the extracellular signals
are not yet fully understood.
Results: We show that Smad3, an intracellular molecule involved in the transforming growth factor (TGF)-β
signaling cascade, is strongly expressed by granule cells in the dentate gyrus (DG) of adult mice, although the loss
of Smad3 in null mutant mice does not affect their survival. Smad3 is also expressed by adult progenitor cells in the
subgranular zone (SGZ) and more specifically, it is first expressed by Type 2 cells (intermediate progenitor cells). Its
expression persists through the distinct cell stages towards that of the mature neuron. Interestingly, proliferative
intermediate progenitor cells die in Smad3 deficiency, which is associated with a large decrease in the production
of newborn neurons in Smad3 deficient mice. Smad3 signaling appears to influence adult neurogenesis
fulfilling distinct roles in the rostral and mid-caudal regions of the DG. In rostral areas, Smad3 deficiency
increases proliferation and promotes the cell cycle exit of undifferentiated progenitor cells. By contrast, Smad3
deficiency impairs the survival of newborn neurons in the mid-caudal region of the DG at early proliferative
stages, activating apoptosis of intermediate progenitor cells. Furthermore, long-term potentiation (LTP)
after high frequency stimulation (HFS) to the medial perforant path (MPP) was abolished in the DG of
Smad3-deficient mice.
Conclusions: These data show that endogenous Smad3 signaling is central to neurogenesis and LTP induction
in the adult DG, these being two forms of hippocampal brain plasticity related to learning and memory that
decline with aging and as a result of neurological disorders.
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New neurons generated in the adult DG are constantly
integrated into the hippocampal circuit. Several lines of
evidences suggest that these newborn neurons are in-
volved in learning and memory, particularly in pattern
separation between similar contexts, a significant mech-
anism of memory formation [1-3], although it remains* Correspondence: amelia.capelo@hrc.es
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distribution, and reproduction in any mediumunclear how neurogenesis contributes to these cognitive
processes. The rodent hippocampus displays a longitudinal
(septotemporal) functional compartmentalization, whereby
the rostral region is associated primarily with cognitive
functions, and the more caudal regions with stress, emotion
and affectivity [4]. This compartmentalization may produce
different neurogenic environments that are associated with
distinct rates of proliferation and/or differentiation [5,6]. In
this sense, it appears that the increased survival of newborn
neurons promoted by spatial learning tasks may be re-
stricted to the rostral DG [7].Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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proliferation of neural progenitors, cell fate specification,
differentiation, maturation, migration and functional in-
tegration into the preexisting neuronal circuitry. In the
adult DG, the cascade of neuronal differentiation is first
characterized by the presence of a class of neural stem
cells, radial glia-like (RGL) cells, believed to be largely
quiescent and known to be nestin+GFAP+. Non-radial
precursors represent another type of neural stem cells
that are Sox2+GFAP-, that lack radial processes and that
are more mitotic than RGLs, although most of them are
not always in the cell cycle [8]. Asymmetric divisions of
neural stem cells generate the amplifying of intermediate
progenitor cells (or Type 2 cells), which exit the cell
cycle within 1–3 days after several rounds of symmetric
divisions to become post-mitotic neuroblasts (or Type 3
cells), which then differentiate into neurons [9,10].
The molecular mechanisms that govern these sequential
developmental events in the adult DG are not completely
understood, although the tight coordination between cell-
intrinsic programs and external signals within the neuro-
genic niche seems to be required [11]. Indeed, extracellular
signals that regulate survival and integration, such as the
neurotrophic factors BDNF, FGF-2 and NT-3 [12-14], or
the neurotransmitters GABA [12,15,16] and Glutamate
[17,18], require intracellular modulators to transduce these
signals. In this sense, it has been described the role of Prox1
in transducing Wnt singaling [19], CREB signaling in
GABA-mediated excitation [20] or NFATc4 for BDNF-
driven survival signaling [21] in adult hippocampal neuro-
genesis (AHN).
TGF-β1 is a pleiotropic cytokine highly expressed in neu-
rodegenerative disorders like Parkinson’s or Alzheimer’s
disease. We recently found that Smad3 deficiency, an intra-
cellular molecule involved in TGF-β signaling cascade, pro-
motes nigrostriatal dopaminergic neurodegeneration
and α-synuclein aggregation [22]. Other studies have
shown that the loss of TGF-β1 activity contributes to
tau pathology and β-amyloid deposition [23], both path-
ologies associated with alterations in cognitive pro-
cesses and AHN. Indeed, it has been suggested that
dysfunctional neurogenesis may exacerbate neuronal
vulnerability to the disease [24].
In this study we have addressed the role of Smad3 in
adult DG neurogenesis and its impact on synaptic trans-
mission. Previous studies in another neurogenic region,
the subventricular zone, identified a reduction in prolifer-
ating cells in Smad3ex8/ex8 mice (a targeted deletion strat-
egy to avoid activation of Smad3 by its receptor) and
reduced migration to the olfactory bulb [25]. To study the
DG, we have used a Smad3 null mouse in which there is a
targeted deletion of the start codon and hence, no expres-
sion of the Smad3 protein [22]. In this model, we show
that Smad3 deficiency promotes the death of intermediateprogenitor cells. Furthermore, Smad3 provokes distinct ef-
fects on the rostral and middle-caudal regions of the DG.
Accordingly, in the rostral domain there is enhanced pro-
liferation and cell cycle exit of proliferative progenitor
cells, which is not observed in the middle-caudal region.
Furthermore, apoptosis is induced at intermediate pro-
genitor cell stage, which strongly diminishes adult neuro-
genesis in the middle-caudal region. Indeed, Smad3
deficiency abolishes LTP formation in the DG, identifying
Smad3 as a fundamental element driving cellular and syn-
aptic plasticity in the DG.
Results
Smad3 deficiency does not alter granule neuron survival
in the DG
The expression of the Smad3 transcription factor in the
neurogenic region of the adult hippocampus has yet to be
analyzed in detail. Through in situ hybridization using a
specific probe against Smad3, we found Smad3 transcripts
to be strongly expressed in the CA1-CA3, hilus and DG
regions of the hippocampus. Indeed, cells expressing
Smad3 were detected in the SGZ, the proliferative region
of the DG (Figure 1A, arrow). The post-mitotic neuronal
specific nuclear protein (NeuN) was co-expressed with
Smad3 in the granular cells of the DG (Figure 1B). Indeed,
the SGZ contained a mixed population of cells that
expressed different levels of NeuN and Smad3 (Figure 1C,
arrows), probably reflecting the process of neuronal mat-
uration. Smad3 could be detected in both the cytoplasm
and the nucleus of mature granule neurons. Indeed,
phospho-Smad3 was also observed in these subcellular lo-
cations (Figure 1D), suggesting that the Smad3 signaling
pathway may be active in these neurons.
As Smad3 null mice develop to adulthood [22], we took
advantage of this genetic model to study the contribution
of Smad3 to the adult DG. We previously showed that
Smad3 promotes the postnatal survival of dopaminergic
neurons in the substantia nigra [22]. Thus, to evaluate
whether Smad3 imparts a survival signal to mature neu-
rons of the granule cell layer (GCL), which are generated
during embryonic development, we estimated the number
of granule neurons in the DG of Smad3 knockout mice in
the basal state. The hippocampus of Smad3−/− mice had a
generally normal morphology (Figure 1B, E), with no alter-
ation in the volume of the DG (P = 0.220) or the hilus
(P = 0.730) compared with Smad3+/+ littermates (Figure 1F).
The number of Nissl stained neurons estimated by un-
biased stereological methods was similar in Smad3+/+ and
Smad3−/− mice (P = 0.941). Furthermore, a similar number
of pyknotic nuclei were evident in the GCL (P = 0.734) and
the hilus (P = 0.398) of both genotypes, suggesting that cell
death was not altered by the Smad3 deficiency. These re-
sults suggest that the prosurvival effect of Smad3 in dopa-
minergic neurons of the adult substantia nigra was not
Figure 1 Smad3 deficiency does not alter the survival of mature granule neurons in the DG. (A) Smad3 mRNA expression was assessed by
in situ hybridization on coronal sections of the adult hippocampus from wild-type mice. The arrow indicates Smad3 mRNA expression in cells
located in the SGZ of the DG. The sense probe, used as a control, produced no staining. (B) Confocal images of Smad3/NeuN double labeling in
the DG of Smad3+/+ and Smad3−/− mice highlighting the generally normal morphology in Smad3 null mice. Scale bar 100 μm. (C) Smad3 is
expressed by mature granule neurons of the DG, both in the cytoplasm and nucleus. In SGZ cells, strong (arrowhead) and weak (arrow) Smad3
expression was detected. (D) Phospho-Smad3 is present in the cytoplasm and nucleus of mature granule neurons. (E) Smad3 null mice do not
express Smad3 protein. Sections from three mice were analyzed and representative images are shown. Scale bar 10 μm. (F) In the DG, unbiased
stereological methods were used to estimate the volume and the number of Nissl stained neurons or that of pyknotic nuclei in Smad3+/+ and
Smad3−/− mice (n.s., student’s t-test, n = 6 mice per genotype).
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or striatum. Furthermore, Smad3 does not seem to play a
central role during the development of these three brain
regions [22].
Smad3 is expressed in SGZ progenitors
We evaluated whether the expression of Smad3 in the
SGZ (Figure 1A, arrow) might be related to the neurogenic
processes in this region. By studying the immunolabeling
for different markers and using confocal microscopy, we
assessed the expression of Smad3 at specific stages of
neuronal maturation: in quiescent RGL (Type-1) cells,intermediate progenitor cells (Type-2 cells), neuroblasts
(Type-3 cells), immature neurons, and in mature granule
neurons (Figure 2A) [10]. Although we could detect
Smad3 expression in GFAP(+) cells with a morphological
extension resembling a radial branch (Figure 2D), no
Smad3 expression could be observed in nestin(+) or Sox2
(+) cells (Figure 2B-C). Similar results were found using
the anti-phospho-Smad3 antibody (data not shown), sug-
gesting Smad3 was not expressed in either RGL or non-
radial neural precursors. However, we could detect weak
expression of Smad3 in Mash1(+) cells, which are early
intermediate progenitor cells (Figure 2E). Indeed, Smad3
Figure 2 Expression of Smad3 at different stages of neuronal precursor maturation. (A) In the prevailing model of AHN, quiescent radial
glia-like cells (RGL or Type-1 cells) generate proliferative precursors known as intermediate progenitors cells (Type-2 cells), which give rise to
neuroblasts (Type-3 cells), then to immature neurons and finally generating mature granule neurons. The identification of the different type of
cells is based on the expression of specific precursors and lineage markers. Confocal microscopy images of (B) Nestin/Smad3, (C) Sox2/Smad3,
(D) GFAP/Smad3, (E) Mash1/Smad3, (F) DCX/Smad3 double-labeled cells with no dendrite maturation, indicative of Type 2b or neuroblast cells,
and (G) with dendrite maturation indicative of immature neurons. Scale bar 10 μm.
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different morphologies, from DCX(+) cells with a rounded
or flattened nuclear morphology (Figure 2F), possibly repre-
senting late phases of type-2 cells and neuroblast stages, to
DCX(+) cells with clear dendrite maturation that may repre-
sent immature neurons (Figure 2G) [26,27]. Indeed mature
neurons labeled with NeuN (Figure 1B-D) also expressed
Smad3, suggesting that Smad3 is expressed at the neuro-
blast, immature and mature granule neuron stages.
These data suggest that Smad3 is not present in RGL or
non-radial neural precursors but rather, that it begins to
be expressed by intermediate progenitor cells, and that it
persists through to the stage of the mature neuron.
Rostral increase in proliferative cells in the absence of
Smad3
Given the presence of Smad3-immunoreactive (−ir) pre-
cursor cells in the adult SGZ, we hypothesized that thissignaling pathway could mediate an intrinsic mechanism
that regulates AHN. We examined Smad3 expression in
proliferating cells identified by in vivo BrdU labeling of
dividing cells, and we found Smad3 to be expressed in
BrdU-ir cells in the SGZ, GCL and the hilus of mice
(Figure 3D). To determine whether Smad3 might influ-
ence cell proliferation in the DG, mice received five daily
BrdU injections and they were then sacrificed 2 days
after the last injection. We estimated the number of
BrdU-labeled cells and we found no overall difference in
the number of proliferative precursor cells in the SGZ,
GCL or hilus (Figure 3A), nor when we considered both re-
gions of the DG (SGZ+GCL) of Smad3-deficient and wild-
type mice (Smad3+/+, 709.5 ± 105.9; Smad3−/−, 739.3 ±
78.87; P = 1.000). However, when these values were
expressed along the rostrocaudal axis of the SGZ, we ob-
served a 2.42-fold increase in BrdU-ir cells in the rostral
portion of Smad3−/− mice with respect to those in wild-
Figure 3 Smad3 promotes the proliferation of NPCs in the rostral DG. To analyze the proliferation of progenitor cells, mice received a daily
injection of BrdU (100 mg/Kg) over 5 consecutive days and they were sacrificed 2 days after the final injection. (A) Smad3 deficiency did not affect the
number of BrdU-ir cells in the SGZ, GCL or the hilus. (B-C) Representation of the SGZ along the rostro-caudal axis showed that Smad3−/− mice had
more BrdU-ir cells in the initial rostral 500 μm but not in the middle and caudal regions of the SGZ (*, P≤ 0.05, Student t-test, n = 5-7 mice per
genotype). (D) Confocal images showing Smad3 expression in BrdU labeled proliferative cells of the SGZ. Scale bar 200 μm and 10 μm. (E-F) The
endogenous marker of cell proliferation Ki-67 further confirmed the enhanced progenitor cell proliferation in the initial 750 μm rostral portion of the
DG in Smad3−/− mice compared to that in Smad3+/+ mice (*, P≤ 0.05, Student’s t-test, n = 5-6 mice per genotype). (G) The number of Nissl stained
neurons in the rostral DG showed a non-statistical trend to increase in Smad3−/− mice in the rostral DG (P = 0.054, Student’s t-test, n = 6 mice
per genotype).
Tapia-González et al. Cell Communication and Signaling 2013, 11:93 Page 5 of 15
http://www.biosignaling.com/content/11/1/93type mice (first 500 μm; Smad3+/+, 57.7 ± 9.8; Smad3−/−,
139.3 ± 39.6; P = 0.041; Figure 3B-C). To confirm this, we
examined the endogenous marker of proliferation Ki-67.
While there was also a similar total number of cells ex-
pressing Ki-67 in the DG of Smad3−/− mice and their
Smad3+/+ littermates (Smad3+/+, 301.0 ± 53.0; Smad3−/−,
336.3 ± 21.6; P = 0.594), the rostral portion of the DG
had 83% more Ki-67-ir cells in Smad3−/− mice than in
Smad3+/+ mice (first 750 μm; Smad3+/+, 69.0 ± 9.1;
Smad3−/−, 126.3 ± 20.5; P = 0.020; Figure 3E-F). We re-
examined the number of Nissl stained cells in this portion
of the DG to search for a rostral increase in the number of
mature granule neurons. We detected a trend towards an
increase in the number of granule neurons in Smad3 defi-
cient mice (23.8%) compared with their control littermates
(first 500 μm; Smad3+/+, 40986 ± 3406; Smad3−/−, 50797 ±
2823; P = 0.059; Figure 4F), although this strong trend did
not quite reach statistical significance. Overall, these re-
sults suggest that although Smad3 is expressed in progeni-
tor cells along the rostrocaudal axis of the DG, it inhibits
proliferation in the rostral but not in the middle or caudal
regions of the DG.Smad3 is critical for adult neurogenesis in the DG
The survival of the progeny of progenitor cells was exam-
ined 28 days after the last BrdU injection. To define the
survival ratio, we compared the number of BrdU-ir cells
observed at 28 days to those counted 2 days after BrdU in-
jection. Smad3+/+ mice had 57.1% fewer BrdU-ir cells in
the DG after 28 days (Figure 4A; 329.0 ± 34.5; P < 0.001)
than on day 2 after injection (Figure 3A). However, in
Smad3−/− mice there were 75.1% fewer BrdU-ir cells on
day 28 (186.2 ± 32.9; p < 0.001), representing a 43.3% re-
duction in their survival (P = 0.016). There was no differ-
ence in the cell diameter of granule neurons between
these mice (Smad3+/+, 7.84 ± 0.23 μm; Smad3−/−, 8.29 ±
0.21 μm; P = 0.145). In the hilus no significant differences
in BrdU-ir cell number were detected between the groups.
The poorer survival of BrdU-ir cells in Smad3−/− mice was
evident in the middle and caudal regions of the DG
(Figure 4B-C; Smad3+/+, 291.5 ± 31.3; Smad3−/−, 146.9 ±
24.0; P = 0.007), while similar survival was detected in the
rostral portion of the null mutants and their wild-type lit-
termates (first 500 μm; Smad3+/+, 37.6 ± 8.9; Smad3−/−,
40.5 ± 12.9; P = 0.930). The distribution of newborn cells in
Figure 4 Smad3 deficiency decreases adult neurogenesis in the DG. Mice received a daily injection of BrdU (100 mg/Kg) on five consecutive
days and the survival of newborn cells was evaluated 28 days after the last injection. (A) Effect of Smad3 deficiency on the survival of newborn
cells labeled with BrdU in the SGZ, GCL and the hilus. (B-C) Representation of the DG (SGZ + GCL) along the rostro-caudal axis showed that
Smad3−/− mice had fewer BrdU-ir cells than Smad3+/+ in the middle and caudal regions, but not in the rostral regions (*, P≤ 0.05; **, P≤ 0.01
Student’s t-test, n = 5-7 mice per genotype). (D) Effect of Smad3 deficiency on progenitor differentiation to neurons (BrdU/NeuN) and (E)
astrocytes (BrdU/S100β; **, P≤ 0.01, Student’s t-test, n = 4-5 mice per genotype).
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two genotypes and thus, both regions of the DG were con-
sidered in the rest of the analyses.
We investigated the differentiation fate of the precursor
cells by double-labeling with BrdU and with neuronal
(NeuN) or astrocyte (S100β) markers. The percentage of
progenitor cells that differentiated into astrocytes did not
differ between Smad3+/+ (12.2 ± 3.4%) and Smad3−/− mice
(13.2 ± 3.3%; P = 0.850; Figure 4E). By contrast, the percent-
age of BrdU-ir cells that were also labeled for NeuN was
68.3 ± 4.34% in Smad3−/− mice, significantly lower than in
wild-type mice (90.8 ± 2.1%, P = 0.009). Overall, the number
of neurons produced in the Smad3−/− mice in one month
was 44.4% less than in their wild-type littermates (Smad3+/+,
377.8 ± 15.0; Smad3−/−, 210.0 ± 37.1; P = 0.014), suggesting
a key role for Smad3 intracellular signaling in AHN.
Cell cycle progression
It is well established that TGF-β signaling has cytostatic
activities and in particular, that Smad3 inhibits cell cycle
progression from the G1 to S phase [28,29]. Hence, wesought to determine whether the decrease in neurogen-
esis associated with Smad3 deficiency was related to al-
terations in the cell cycle progression of progenitor cells.
We examined whether the proportion of progenitor cells
in the S phase or G2/M phases of the cell cycle, and
their index of cell cycle exit, was altered in Smad3 null
mice. The mitotic activity of progenitor cells was evalu-
ated through the incorporation of BrdU in pulse-labeling
assays. Wild-type and Smad3 null mice were analyzed
30 minutes after a single BrdU injection (150 mg/Kg,
Figure 5A), a labeling regime that is sufficient to saturate
the proliferative cells in S phase. A second group of mice
was analyzed 8 hours after the same dose of BrdU was
administered, double-labeling BrdU-ir cells with pHisH3,
a marker of the G2/M phases of the cell cycle. At this
time point after the BrdU pulse, the co-localization of
BrdU and pHisH3 is maximal [30,31]. Finally, mice were
analyzed 24 h after BrdU labeling to study cell cycle exit,
through the co-localization of BrdU and Ki-67, a marker
of the G1/S/G2/M phases that is downregulated after cell
cycle exit [32].
Figure 5 Cell cycle progression in Smad3−/− mice. (A) Scheme of the experimental design to study cell cycle progression in Smad3 deficient
mice. Mice were sacrificed 30 minutes, 8 hours and 24 hours after receiving a single dose of BrdU (150 mg/Kg). (B) Confocal images of BrdU and
pHisH3 double-labeled cells 8 hours after pulse-labeling with BrdU. BrdU/Ki-67 double-labeled cells were assessed 24 hours after BrdU injection.
Scale bar 25 μm. (C) Number of cells in S phase (labeled with BrdU) 30 minutes after delivering the BrdU pulse, and of cells in the G2/M phase
(double-labeled with BrdU and pHisH3) 8 hours after pulse labeling (n.s., two-way ANOVA n = 3-5 mice per genotype). (D-E) The index of cell cycle
exit in wild-type and Smad3−/− mice showing an increase in the rostral DG. The index of cell cycle exit was scored by defining the ratio between
BrdU+Ki67- cells and total BrdU+ cells in the DG, which corresponds to the fraction of precursors that have left the cell cycle within 24 hours
(**, P≤ 0.01, Student’s t-test, n = 5 mice per genotype).
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30 minutes after pulse-labeling was similar in Smad3−/−
mice and their control littermates (Smad3+/+, 734.2 ±
76.8; Smad3−/−, 773.8 ± 128.8; Figure 5C), as were the
number of precursor cells that had entered the G2/M
phases 8 hours after the BrdU pulse. Accordingly, there
were 407.5 ± 28.8 and 415.5 ± 65.1 BrdU+pHisH3+ cells
in Smad3+/+ and Smad3−/− mice, respectively [two-way
ANOVA, F(1, 14) = 0.001; no effect of genotype (P = 0.822),
time after BrdU labeling (P = 0.118) or interaction (P =
0.972)]. These results suggest that in progenitor cells, the
S/G2/M phases of the cell cycle were not altered in Smad3
deficient mice.
In standard situations, cells divide as they pass through
the M phase of the cycle, while some exit the cell cycle at
G1 and others re-enter in S phase. We scored the index of
cell cycle exit 24 hours after pulse-labeling with BrdU, de-
fining the ratio between BrdU+Ki67- cells and the total
numbers of BrdU+ cells in the DG, which corresponds to
the fraction of precursors that have left the cell cyclewithin 24 hours [32-34]. There was a significant increase in
the cell cycle exit index in the rostral portion of Smad3−/−
relative to control mice (Smad3+/+, 2.98.40 ± 0.94%;
Smad3−/−, 9.55 ± 1.63%; P = 0.008) but not in the middle
and caudal regions (Figure 5D-E), confirming the different
behavior of progenitor cells in these areas of the DG. To-
gether these data suggest that Smad3 deficiency does not
alter cell cycle progression through S/G2/M, although in-
activating Smad3 signaling in the rostral DG affects the
decision to exit the cell cycle.
Fewer intermediate progenitor cells in Smad3
deficient mice
We next focused on the total number of BrdU-ir cells
present 30 min, 8 h and 24 h after pulse labeling mice
(Figure 6A). Two-way ANOVA analyses showed an inter-
action between genotype and time after BrdU pulse label-
ing (F(2, 23) = 3.936; P = 0.038). There was no difference
between Smad3+/+ and Smad3−/− in terms of the total
number of BrdU-ir cells present 30 minutes (P = 0.843) or
Figure 6 Smad3 deficiency leads to apoptotic cell death and fewer intermediate progenitor cells. (A) The total number of BrdU-ir cells
30 minutes, 8 hours and 24 hours after delivering the BrdU pulse (150 mg/Kg: **, P ≤ 0.01, two-way ANOVA, Holm-Sidak post hoc test n = 3-5 mice
per genotype). (B) Histograms showing the total number of activated caspase 3-ir cells and those double-labeled with BrdU in the DG (*, P≤
0.05, **, P ≤ 0.01, Student t-test, n = 3 mice per genotype). (C) Confocal images of activated caspase 3/BrdU double-labeling, 24 hours after BrdU
injection showing apoptotic BrdU-ir cells in the DG. Scale bar 10 μm. (D) Confocal image showing nuclear activated caspase 3 in intermediate
progenitor cells expressing Mash1 in the cytoplasm. Cell shrinkage morphology, nuclear condensation and fragmentation and activated caspase 3
are suggestive of apoptosis. Scale bar 10 μm. (E-F) Quantification of the number of Mash1(+) cells in the DG along the rostro-caudal axis showed
that Smad3+/+ mice had fewer intermediate progenitor cells (**, P≤ 0.01, Student t-test, n = 6 per genotype).
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were 24.5% fewer BrdU-ir cells 24 hours after pulse label-
ing in Smad3−/− mice than in their Smad3+/+ littermates
(Smad3+/+, 1345.8 ± 54.45; Smad3−/−, 1016.4 ± 75.9; P =
0.004). To evaluate whether progenitor cells might
undergo apoptosis in the absence of Smad3 signaling at
this early stage, we analyzed the expression of activated
caspase 3 in the DG. The number of apoptotic cells
increased significantly in Smad3−/− mice compared to
their wild-type littermates, as evident through both the
total number of cells expressing activated caspase 3
(Smad3+/+, 100.0 ± 19.1; Smad3−/−, 371.7 ± 42.6; P =
0.004) and through the number of apoptotic BrdU-ir cells
(Smad3+/+, 20.0 ± 12.6; Smad3−/−, 95.8 ± 11.2; P =
0.011; Figure 6B-C). Thus, the net reduction in the
production of newborn adult hippocampal neurons ob-
served in Smad3-deficient mice (Figure 4) seems to be
the result of activating the apoptotic program in undif-
ferentiated progenitor cells.
Because Smad3 is first expressed at the intermediate
progenitor cell stage, we examined whether theseproliferative cells might be dying in the absence of Smad3.
Indeed, we could detect active caspase 3 in Mash1(+) cells
(Figure 6D) and Smad3−/− mice had 33.9% fewer Mash1(+)
cells in the DG than Smad3+/+ littermate mice (Smad3+/+,
407.9 ± 25.0; Smad3−/−, 269.8 ± 26.3; P = 0.003;
Figure 6E-F). Together, these data indicate that Smad3
signaling is central to AHN, regulating the survival of
proliferative intermediate progenitor cells along the
rostro-caudal axis.
LTP is abolished in Smad3-deficient mice in the DG
We evaluated the impact of the decreased neurogenesis
provoked by Smad3 deficiency on hippocampal LTP.
The strongest induction of LTP in the DG was obtained
by applying HFS to the MPP [35], which in wild-type
mice resulted in a rapid and stable potentiation of the
evoked field excitatory postsynaptic potentials (fEPSPs)
slope (146.0 ± 11.1%, P < 0.001; Figure 7A). In Smad3
knockout mice, HFS was not followed by induction of
LTP (94.0 ± 7.2%, P < 0.460; Figure 7B). In contrast to
the DG, HFS of the Schaffer collateral pathway evoked
Figure 7 Smad3 deficiency abolishes LTP induction in the DG after HFS of the MPP. (A) LTP induction in the DG of Smad3+/+ mice. (B)
Smad3−/− mice do not exhibit evoked LTP in the DG. (C-D) HFS induces LTP in the CA1 region of Smad3+/+ and Smad3−/− mice. Raw fEPSP data
(a) before tetanus, (b) 15 min and (c) 120 min after tetanus administration.
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mice (164.8 ± 13.8%, P < 0.001; Figure 7C) and in Smad3−/−
mice (176.2 ± 20.6%, P < 0.001; Figure 7D). Control experi-
ments showed that these effects were not caused by
electrode-induced injury, synaptic activation or granule cell
DG discharges, because there was no significant difference
in the input/output curves for the same group of animals
(data not shown).Discussion
For the first time, we have identified a central role for
Smad3 signaling in controlling the survival of prolifera-
tive intermediate progenitor cells and the rate at which
newborn neurons are produced in the adult DG. Not-
ably, Smad3 is not required for the survival of mature
granule neurons generated during embryonic develop-
ment, as also observed for neurons in other brain re-
gions [22]. Moreover, Smad3 deficiency abolishes LTP
in the DG, while LTP induction in the CA1 is evokedcorrectly, indicating a central role for Smad3 in DG cel-
lular and synaptic plasticity.
Smad3 is not present in neural stem cells (radial and
non-radial precursors) labeled with Sox2 or nestin markers.
We have found a small number of GFAP+Smad3+ cells
with a cell body residing in the DG and a radial process ex-
tending into the granule layer, however they seems not to
be RGL precursors. It is already known the heterogeneity
of RGL cells, with subpopulations identified by different
markers [36] or properties, such as proliferative or quies-
cence, although with similar morphology [10]. However,
we have found GFAP+Smad3+ cells near vessels, suggesting
that they could be astrocytes. Further studies will clarify
whether these cells might meet the specific criteria for
stem cells or could be classified as astrocytes. Smad3 co-
localizes with Mash1, a specific marker of intermediate
progenitor cells, and its expression persists in neuroblasts,
immature and mature neurons. Intermediate progenitor
cells are the most proliferative cell type in the adult DG
[10], and this expression suggest that Smad3 may have a
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progenitor cells and post-mitotic newborn neurons. In-
deed, proliferative intermediate progenitor cells die in the
absence of Smad3, inducing a strong decrease in the rate
at which newborn neurons are generated.
Through BrdU pulse-labeling we found that the S and
G2/M phases of the cell cycle are not modified in the ab-
sence of Smad3. However, inactivating Smad3 signaling in
the rostral DG increases the decision to exit the cell cycle,
as detected 24 h after BrdU pulse-labeling through the co-
localization of BrdU and Ki-67. Ki67 is a marker of prolif-
eration expressed during the G1/S/G2/M phases of the cell
cycle, which it is downregulated after cell cycle exit and
absent in resting cells [32-34]. The short half-life of Ki67,
estimated to be around 60 to 90 minutes [37,38], avoids
the accumulation of non-degraded protein soon after cell
cycle exit. Considering that the cell cycle length of precur-
sor cells in the DG is 14 hours [31], Ki67 labeling of cells
that incorporated BrdU 24 hour previously allows pro-
genitor cells that have left the cell cycle to be discerned.
The observed result suggests a potential role for Smad3 in
regulating G1 phase, where the cell cycle exit decision is
made [39]. BrdU pulse-labeling also shows that Smad3 de-
ficient cells die through apoptosis 24 h after injection. It is
already known that the majority of proliferating cells that
have incorporated BrdU 2 to 24 hours after injection are
intermediate progenitor cells [40,41], and it is estimated
that intermediate progenitor cells can pass through up to
five cell cycles as transient amplifying cells [42]. Hence, we
might envisage that transit amplifying intermediate pro-
genitor cells deficient in Smad3 signaling activate apop-
tosis during their cell cycle.
TGF-β/Smad3 signaling is known to fulfill a central role
in cell cycle progression and apoptosis [43]. TGF-β signal-
ing inhibits cell growth through its cytostatic activity. In
particular, Smad3 inhibits the progression of epithelial
cells from the G1 to S phase of the cell cycle, and in other
cell types albeit to a lesser extent [29]. Smad3 induces cell
cycle arrest by inhibiting cyclin-dependent kinases (Cdk)
and key transcriptional regulators, such as c-Myc and the
Id family of proteins [28]. In the early G1 phase, cell cycle
progression is driven by the concerted action of Cdk4 and
Cdk6, whereas Cdk2 is the driving force during late G1
phase [44]. It has already been shown that Cdk6, but not
Cdk4 or Cdk2, is required for AHN [33,45]. In addition, to
ensuring correct progression through the cell cycle, there
are internal checkpoints that monitor the conditions to
generate healthy daughter cells, and cell damage or stress
may restrict cell cycle progression and/or induce cell
death, through them. The G1/S checkpoint protects gen-
omic integrity and prevents damaged cells from entering
S-phase by inducing apoptosis [46-48]. In this sense, alter-
ation to the G1/S checkpoint in the absence of Smad3
could lead intermediate progenitor cells to undergoapoptosis. Thus, one might envisage a model where
Smad3 is actively involved in ensuring that proliferative
precursors pass the G1/S checkpoint, preventing them
from undergoing premature apoptosis and diminishing
neurogenesis. Considering that the transition from inter-
mediate progenitor cells to neuroblasts is the main critical
period in the survival of newborn cells [49], Smad3 signal-
ing appears to be a key molecule for the survival of new-
born neurons.
It is notable that Smad3 deficiency produces different
effects on progenitor cells in the rostral or middle-
caudal regions of the DG. In the rostral portion, the in-
crease in proliferation, and in cell cycle exit, induced by
Smad3 deficiency was not translated into a clear increase
in newborn neurons, probably due to the activation of
apoptosis and cell death at the intermediate progenitor
cell stage. Since newborn neurons contributes to only a
minor fraction of the adult DG granule cell population
[50,51], this would explain why no clear increment in
the number of mature granule neurons can be observed
in the rostral DG. On the other hand, the rostral in-
crease in proliferation could be a mechanism to com-
pensate for cell death and to maintain cell numbers in
the rostral DG. Conversely, increased proliferation is not
observed in the middle-caudal region and the induction
of apoptosis at the intermediate progenitor cell stage
strongly dampens adult neurogenesis.
An interaction of Smad3 with rostral or middle-caudal
specific signals may account for this differential effect.
On the other hand, a gradient of Smad3 expression may
exist. Indeed, during development Smad3 regulates axis
formation through Nodal, one of the best characterized
morphogens involved in anterior-posterior embryonic
patterning [52]. However, we could not detect stronger
Smad3 expression in the rostral portion of the DG of
adult mice (data not shown), nor in other areas of the
brain such as the substantia nigra, a structure where we
previously detected a rostral effect of Smad3 on the sur-
vival of dopaminergic neurons [22], suggesting a func-
tional spatial differentiation of this signaling molecule.
The longitudinal functional compartmentalization of the
hippocampus may produce different neurogenic environ-
ments, in which distinct rates of proliferation and/or dif-
ferentiation may be established [5-7]. The different effect
of Smad3 on adult neurogenesis along the rostrocaudal
axis of the DG might participate in this functional longitu-
dinal compartmentalization of the hippocampus, promot-
ing a distinct neurogenic environment in rostral regions.
Several ligands may activate Smad3, such as TGF-
β1, -β2, -β3, activin or GDF1. It is already known that
through Smad2/3 signaling, TGF-β controls self-renewal
and differentiation in several types of stem cells [53]. Indeed,
the role of TGF-β in AHN has been investigated using ex-
ogenous administration or transgenic overexpression of this
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depend on the experimental model [54-56]. Bearing in
mind that the effects of TGF-β1 are dose- and context-
dependent [43], its overexpression may introduce a bias in
studies carried out under physiological conditions. Activin
overexpression has also produced conflicting results when
studying adult DG neurogenesis. In activin transgenic
mice there is apparently no effect on neurogenesis [57], al-
though i.c.v. infusion of the protein led to an increase in
precursor cell number in another study [58]. When activin
is experimentally inhibited by using its high-affinity antag-
onist follistatin, a marked decrease in neurogenesis is ob-
served in uninjured transgenic mice and following i.c.v.
infusion after excitotoxic neurodegeneration. However,
follistatin may also have antagonist activity against other
members of the TGF-β superfamily, such as TGF-β1,
BMP4 or BMP7 [59,60], raising the possibility that the in-
hibitory effect of follistatin on neurogenesis could be me-
diated by other TGF-β molecules. In this sense, the
extracellular ligand that may activate Smad3 in the DG to
inhibit adult neurogenesis remains unknown.
Smad3 deficiency abolishes LTP induction in the DG
and the specificity of this effect is evident as LTP is evoked
properly in the CA1 region. A role for TGF-β in neuronal
plasticity has been witnessed in Drosophila and Aplysia
[61,62]. In the rodent hippocampus, Smad4 - which binds
to diverse intracellular Smads that are involved in both
TGF-β (Smad2 and Smad3) and BMP (Smad1, Smad5 and
Smad8) signaling - does not participate in the induction of
LTP in the CA1 hippocampal formation, although it does
influence excitatory/inhibitory transmission, an effect that
seems to be related to BMP signaling [63]. The effect of
Smad3 deficiency on LTP that we detected could involve
the NMDA or GABA receptor, the latter being implicated
in neurogenesis. In the adult mouse brain, GABAergic
transmission regulates proliferation, and it promotes the
differentiation, maturation and functional integration of
newborn neurons into the DG. Indeed, GABAergic input
promotes the differentiation of amplifying intermediate
progenitor cells [16,64,65]. Learning and memory forma-
tion rely on the experience-related modification of synap-
tic structures in the hippocampus and on the induction of
LTP, an activity-dependent change in the synaptic strength
[66]. It has already been shown that the in vivo induction
of LTP at MPP inputs to the DG promotes neurogenesis
[67], and conditional ablation of adult neurogenesis im-
pairs LTP at MPP synapses [68], suggesting that these two
processes are functionally linked. Whether the effect of
Smad3 on neurogenesis might represent a link between
these processes or if they are regulated in an independent
manner will require further study. Furthermore, although
Smad3 deficiency does not alter the number of mature
granule neurons generated during embryonic develop-
ment, we could not exclude a developmental alteration,and that glial cells deficient in Smad3 could also influence
the observed effects. However, Smad3 seems to be a major
contributor to both neurogenesis and LTP induction in
the adult DG, these being two forms of hippocampal brain
plasticity related to learning and memory.
Physiological conditions such as external aversive or
enriching experiences, including stress or learning, may in-
fluence both neurogenesis and LTP [69,70]. Cycling inter-
mediate progenitor cells have been seen to be the target of
neurogenic external stimuli, such as running [40,41]. In
this sense, Smad3 may participate in the physiological
events regulated by neurogenesis. Indeed activin modulates
anxiety and depression responses in mice [71,72]. On the
other hand, different brain pathologies alter AHN, such as
epilepsy, stroke, inflammation or neurodegeneration [73],
and different forms of dementia and alterations in hippo-
campal neurogenesis are associated with Parkinson’s and
Alzheimer’s disease [24]. Smad3 deficient mice represent
an interesting model to study parkinsonism due to the ef-
fects on nigrostriatal dopaminergic neurodegeneration and
α-synuclein aggregation [22], where overexpression of α-
synuclein may also play a role on hippocampal neurogen-
esis [74]. Further studies will clarify whether this effect of
Smad3 on hippocampal LTP and neurogenesis may be re-
lated to pathological events.
Conclusions
We show here for the first time that endogenous Smad3
signaling is a major contributor to neurogenesis and
LTP in the adult DG, highlighting its role in the intrinsic
mechanisms that govern neuronal precursors and hippo-
campal plasticity.
Methods
RNA In situ hybridization
All steps for RNA in situ hybridization were performed in
a RNase free environment, as described by Young and
Mezey [75]. To generate DIG-labeled antisense and sense
riboprobes, a cDNA fragment of Smad3 (GenBank acces-
sion number NM_016769) was generated by PCR and
cloned into the XhoI/BamHI sites of pCRII (Invitrogen,
Carlsbad, California, USA). The linearized plasmid served
as the template for in vitro transcription using the DIG
RNA Labeling Kit and the SP6/T7 RNA polymerases
(Roche Diagnostics GmbH, Basel, Switzerland). The sense
probe was used as a control and produced no staining.
Unfixed fresh-frozen brains were cryoprotected in
30% sucrose in PBS and embedded in optimal cutting
temperature (OCT) compound (Sakura Finetechnical,
Tokyo, Japan). Coronal cryostat sections (12 μm) were
collected on microscope slides and they were post-fixed
in 4% paraformaldehyde, permeabilized with proteinase K,
acetylated, dehydrated in 70, 80, 95, 100% ethanol, and
delipidized in 100% chloroform. The sections were pre-
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USA) and hybridized at 55°C for 24 hours with the DIG-
labeled riboprobe (500 ng/ml) in the same hybridization
buffer containing 50% formamide. The sections were then
washed extensively in 2X, 1X, 0.1X SSC, in wash buffer
and finally, in blocking buffer for 30 minutes at room
temperature (DIG Wash and Block, Roche). The hybrid-
ized probes were detected using an anti-DIG alkaline
phosphatase-conjugated antibody (Roche Molecular
Biochemicals) diluted 1:1000, which was visualized with
the alkaline phosphatase substrates nitroblue tetrazolium
chloride and 5-bromo-4-chloro-3-indolyl phosphate di-
luted in a solution containing levamisole (Sigma). The re-
action was developed for 1–2 hours at room temperature
under observation to determine the optimal signal to noise
ratio, and it was then quenched by rinsing in 1X SSC. The
sections were subsequently air-dried, mounted in Cytoseal
60 (Electron Microscopy Sciences, Hatfield, Pensilvania,
USA) and visualized on an Olympus (Tokyo, Japan) BX51
microscope.
Mouse line
Smad3 wild-type and knockout mice were obtained by
breeding heterozygous mice, and they were characterized
by PCR analysis of tail biopsies [22]. 3-4-month-old female
mice were group housed, maintained on a 12/12 hour
light/dark cycle, and provided with ad libitum access to
food and water. The half-lives of female Smad3−/− mice is
16.2 ± 2.0 months. All procedures involving mice were
carried out in accordance with EU and Spanish legislation
on the care and use of experimental animals. The stage of
the estrous cycle was determined for a minimum of two
weeks before treatment by examining the appearance of
the vagina [76], with more than 95% of animals found to
be cycling normally.
BrdU treatment
Labeling of hippocampal dividing cells was performed
by administering i.p. injections of 5-bromo-2-deoxyuri-
dine (BrdU, 10 mg/ml; Sigma) dissolved in 0.9% NaCl/
7 mM NaOH. Only female mice on the first day of dies-
trus were used, thereby ensuring that each mouse would
experience the same amount of time in each stage of the
estrous cycle during the injection period [77]. To label
dividing or recently divided cells in sufficient numbers
for quantification, mice received once daily injections of
BrdU (100 mg/Kg) at 5 p.m. on five consecutive days.
For proliferative studies, mice were sacrificed 2 days
after the final injection. For the differentiation analyses
to follow the commitment of these newly divided cells,
mice were sacrificed 28 days after the last injection.
BrdU pulse-labeling assays were performed by injecting
a single dose of BrdU (150 mg/Kg) and sacrificing the
mice 30 minutes, 8 hours or 24 hours later.Immunohistochemistry
Standard chromogenic immunoperoxidase immunohis-
tochemistry was performed [22] using mouse anti-BrdU
(1:100; Dako, Copenhagen, Denmark) and rabbit anti-Ki-
67 (1:500; Abcam, Cambridge, UK) primary antibodies.
For the detection of BrdU-labeled cells, sections were
pretreated for 30 min in 2 N HCl at 37°C to denature
the DNA, and they were then incubated for 10 min in
sodium borate (100 mM, pH 8.5) to neutralize any re-
sidual acid. The Vectastain peroxidase kit (Vector Labs,
Burlingame, CA, USA) was used in accordance with the
manufacturer’s instructions. Double immunofluores-
cence was performed using antigen retrieval and the fol-
lowing antibodies: rabbit anti-Smad3 (1:150; Abcam), rat
anti-BrdU (1:1500; Abcam), rabbit anti-phospho-Smad3
(1:200; Cell Signal, Danver, MA, USA), mouse anti-nestin
(1:200; Millipore, Billerica, MA, USA); mouse anti-GFAP
(1:1500; Chemicon, Temecula, CA, USA), mouse anti-
SOX2 (1:1000; Calbiochem, San Diego, CA, USA), mouse
anti-Mash1 (1:100; BD Biosciences, San José, CA, USA),
mouse anti-NeuN (1:400; Chemicon), goat anti-DCX
(1:300; Santa Cruz, Dallas, TX, USA), rabbit anti-S100β
(1:1000; Millipore), rabbit anti-pHisH3 (1:8000; Santa
Cruz), and rabbit anti-activated caspase 3 (1:800; Cell Sig-
nal). Nissl staining of hippocampal sections was per-
formed using 0.1% cresyl violet (Sigma).
Cell counting and volumetric analysis
All morphological analyses were performed blind, on
coded slices, using a stereological system, as described
previously [22]. BrdU-ir cells were counted in every fifth
section (25 μm thick sections, 125 μm apart) covering
the first 2 mm of the DG from Smad3−/− and Smad3+/+
mice. Each section was observed at low magnification
(objectives 10X and 2X), and an atlas was generated with
contours drawn for the GCL and the hilus, which was
used as a guide. The SGZ is defined as a 2 nucleus-wide
zone below the apparent border between the GCL and
the hilus [78]. The hilus was defined as the area enclosed
by the GCL and a virtual straight line joining the tips of
its two blades [79]. The volume of the GCL and hilus
was estimated using a stereological system by summing
the traced area for each section, and multiplying this by
the section thickness and sampling interval. Pyknotic
cells were identified through their darkly stained and
condensed nucleus, suggestive of chromatin condensa-
tion associated with cell death [80]. Nuclei labeled with
BrdU were counted using a 40X objective, excluding
those cells with a diameter less than 4 μm. The total
number of BrdU-ir cells was estimated by multiplying
the number of profiles by the sampling interval. For cell
phenotyping, co-localization of Smad3 and BrdU with
the different markers was assessed by confocal micros-
copy [22].
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Hippocampal slices were prepared from female Smad3+/+
and Smad3−/− mice when they reached the first day of di-
estrus. Mice were deeply anesthetized with isoflurane and
decapitated, and their brain was removed rapidly and
immersed in ice-cold standard medium containing (in
mM): 119 NaCl, 2.3 KCl, 1.3 MgSO4, 2.5 CaCl2, 26.2
NaHCO3, 1 NaH2PO4 and 11 glucose, saturated with 95%
O2 and 5% CO2 to maintain the pH at 7.4. Transverse
400 μm thick vibratome slices were obtained at 4°C
(1000plus, St. Louis, MO, USA) and they were maintained
in an interface holding chamber [81] at room temperature
(21-25°C) and allowed to stabilize for at least 2 h. Individ-
ual slices were transferred to an open submersion-type re-
cording chamber and perfused continuously (flow rate
1.5-2 ml/min; 30-32°C), measuring the osmolarity of the
perfused solutions (Micro-osmometer 3MO, Advanced In-
struments, Norwood, MA, USA).
fEPSPs were obtained by electrically stimulating the
MPP with biphasic electrical pulses (60 μs) using bipolar
tungsten-insulated microelectrodes (1 MΩ: S88 stimula-
tor, Grass Instrument Co., Quincy, MA, USA). The fEPSPs
were recorded from the medial molecular layer of the DG
using a glass capillary microelectrode filled with standard
medium (tip resistance 1–3 MΩ) and connected to a P15
amplifier (Grass Instrument Co.). A paired-pulse stimulus
at a 50 ms interval was applied to confirm MPP stimula-
tion [35]. The intensity of the stimulation used was that
necessary to obtain one third of the maximum amplitude
response and only slices with a maximum fEPSP ampli-
tude greater than 1 mV were considered. After 15 min of
a stable baseline response (0.05 Hz frequency stimulation),
a tetanic stimulation was applied to induce LTP (four
trains of 1 s each, 100 Hz within the train, repeated every
15 s). To evoke LTP in the CA1, electrodes were posi-
tioned in the stratum radiatum to stimulate the Schaffer
collateral pathway. Recording microelectrodes were posi-
tioned 200–600 μm from the stimulating electrode in the
same stratum.
Evoked responses were low-pass filtered at 3 kHz, digi-
tized at 10 kHz (Digidata 1200 interface, Molecular De-
vices) and stored (Axotape software, Molecular Devices,
Sunnyvala, CA, USA). To determine synaptic strength,
the initial decay of the fEPSP slope was measured 2 ms
after the stimulus (Clampfit software, Molecular De-
vices). The values presented for each minute in the fig-
ures are the average of three consecutive responses. The
data were normalized to the averaged value of the fEPSP
slope (100%) measured 15 min prior to tetanus adminis-
tration (stable baseline response).
Statistical analysis
SigmaStat software (Chicago, IL, USA) was used for all
the analyses and the data were expressed as the mean ±s.e.m. The normal distribution of the data was assessed
and differences between the means were analyzed with
the unpaired Student’s t-test when investigating the ef-
fect of genotype on one variable. The effect of genotype
on more than one variable was assessed using a two-way
ANOVA, followed by a Holm-Sidak’ post hoc test. In all
analyses, the null hypothesis was rejected at the 0.05
level: (*), (**), and (***) indicate P ≤ 0.05, P ≤ 0.01 and
P ≤ 0.001, respectively.
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